Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Atorvastatin Raises Threshold of Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention

NCT04375787 is registered in ClinicalTrials.gov with Mohamed Abdelfatah as lead sponsor.

NCT NCT04375787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Atorvastatin Raises Threshold of Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
Lead sponsor
Mohamed Abdelfatah
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2020
Completion date
June 2, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease